D G Haller
Overview
Explore the profile of D G Haller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
4377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen R, Raeisi M, Chibaudel B, Yothers G, Goldberg R, Bachet J, et al.
ESMO Open
. 2025 Mar;
10(3):104481.
PMID: 40043353
Background: Standard adjuvant treatment of stage III colon cancer (CC) is fluoropyrimidine with oxaliplatin. Recently, stage III was subdivided into low-risk (T1-3, N1) and high-risk (T4 and/or N2), with the...
2.
Renfro L, Grothey A, Kerr D, Haller D, Andre T, Van Cutsem E, et al.
Ann Oncol
. 2015 Feb;
26(5):950-958.
PMID: 25697217
Background: Post-treatment survival experience of early colon cancer (CC) patients is well described in the literature, which states that cure is probable for some patients. However, comparisons of treated patients'...
3.
Haller D, Oconnell M, Cartwright T, Twelves C, McKenna E, Sun W, et al.
Ann Oncol
. 2015 Jan;
26(4):715-724.
PMID: 25595934
Background: Adjuvant oxaliplatin plus capecitabine or leucovorin/5-fluorouracil (LV/5-FU) (XELOX/FOLFOX) is the standard of care for stage III colon cancer (CC); however, there is disagreement regarding oxaliplatin benefit in patients aged...
4.
Adam R, Haller D, Poston G, Raoul J, Spano J, Tabernero J, et al.
Ann Oncol
. 2010 Mar;
21(8):1579-1584.
PMID: 20219759
Metastatic colorectal cancer is a particularly frequent and severe cancer. Patients die mainly from metastatic disease; however, the survival of these patients has dramatically improved with the progress in chemotherapeutic...
5.
Dolinsky C, Mahmoud N, Mick R, Sun W, Whittington R, Solin L, et al.
J Surg Oncol
. 2007 Apr;
96(3):207-12.
PMID: 17443718
Background And Objectives: Preoperative chemoradiotherapy for locally advanced rectal cancer is now considered "standard of care." However, the optimal time interval for resection after neoadjuvant therapy is unknown. Methods: Between...
6.
Veronese M, Sun W, Giantonio B, Berlin J, Shults J, Davis L, et al.
Br J Cancer
. 2005 May;
92(10):1846-9.
PMID: 15870719
Inhibition of epidermal growth factor receptor (EGFR) signalling contributes to the therapy of colorectal cancer. Gefitinib, an oral EGFR tyrosine kinase inhibitor, shows supra-additive growth inhibition with irinotecan and fluoropyrimidines...
7.
Veronese M, Stevenson J, Sun W, Redlinger M, Algazy K, Giantonio B, et al.
Eur J Cancer
. 2004 Feb;
40(4):508-14.
PMID: 14962716
UFT (BMS-200604, Uftoral) is an oral fluoropyrimidine that combines uracil and the 5-fluorouracil (5-FU) prodrug, ftorafur, in a 4:1 molar ratio with single-agent activity in breast and gastrointestinal cancers. In...
8.
Le Voyer T, Sigurdson E, Hanlon A, Mayer R, Macdonald J, Catalano P, et al.
J Clin Oncol
. 2003 Jul;
21(15):2912-9.
PMID: 12885809
Purpose: To determine the relationship, in patients with adenocarcinoma of the colon, between survival and the number of lymph nodes analyzed from surgical specimens. Patients And Methods: Intergroup Trial INT-0089...
9.
Blanke C, Haller D, Benson A, Rothenberg M, Berlin J, Mori M, et al.
Ann Oncol
. 2002 Feb;
12(11):1575-80.
PMID: 11822757
Background: A phase II study testing the safety and efficacy of irinotecan (CPT-11). 5-fluorouracil (5-FU), and leucovorin (LCV) was conducted in patients with advanced gastric adenocarcinomas. Patients And Methods: Patients...
10.
Stevenson J, Redlinger M, Kluijtmans L, Sun W, Algazy K, Giantonio B, et al.
J Clin Oncol
. 2001 Oct;
19(20):4081-7.
PMID: 11600611
Purpose: Irinotecan and raltitrexed display schedule-dependent synergy in vitro, which supports the clinical investigation of the combination. Functional polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene result in intracellular redistribution of...